BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36916388)

  • 41. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells.
    Das B; Sethy C; Chatterjee S; Dash SR; Sinha S; Paul S; Goutam K; Kundu CN
    J Cell Commun Signal; 2023 Dec; 17(4):1371-1388. PubMed ID: 37162635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.
    Dunn LK; Mohammad KS; Fournier PG; McKenna CR; Davis HW; Niewolna M; Peng XH; Chirgwin JM; Guise TA
    PLoS One; 2009 Sep; 4(9):e6896. PubMed ID: 19727403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1.
    McCann JV; Xiao L; Kim DJ; Khan OF; Kowalski PS; Anderson DG; Pecot CV; Azam SH; Parker JS; Tsai YS; Wolberg AS; Turner SD; Tatsumi K; Mackman N; Dudley AC
    J Clin Invest; 2019 Mar; 129(4):1654-1670. PubMed ID: 30855280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells.
    Darbankhales S; Mirfakhraie R; Ghahremani H; Asadolahi M; Saket-Kisomi K; Safakish L; Darbeheshti S; Ganjkhanlou Z; Salami S; Sirati-Sabet M
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3171-3176. PubMed ID: 33247672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade.
    Satapathy SR; Siddharth S; Das D; Nayak A; Kundu CN
    Mol Pharm; 2015 Nov; 12(11):4011-25. PubMed ID: 26448277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
    Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
    Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation.
    Vankayala R; Huang YK; Kalluru P; Chiang CS; Hwang KC
    Small; 2014 Apr; 10(8):1612-22. PubMed ID: 24339243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
    Ma K; Zhang C; Li W
    Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
    Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
    Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
    Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
    Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
    Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
    Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gold-based nanoparticles realize photothermal and photodynamic synergistic treatment of liver cancer and improve the anaerobic tumor microenvironment under near-infrared light.
    Li B; Fu Y; Xie M; Feng L; Niu X; Que L; You Z
    Front Bioeng Biotechnol; 2022; 10():957349. PubMed ID: 36061429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
    Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
    Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.